DFX Intelligence
Family Office Intelligence
A continuously maintained graph of U.S. family offices: identity, team, observed investments, public holdings, relationships and dated signals of change. Facts, inferences and estimates are labelled as such, with the source and the date, on every row. Unknown is printed as unknown.
Family office profile
Q••••• C••••••
The office, people and counterparty names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
New York, NYSingle family office (probable)identity confidence 70%Top 500 by research priority
Why this class: a filing by a third party describes it as a single family office (cited).
Verified Sep 16, 2026 (5 days ago)
Last observed Sep 19, 2026 · 12 observations · 3 sources
3 people · 5 investments · 0 public positions · 6 events
Direct investing
70
high
Private markets
45
elevated
Co-investment
50
elevated
Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, sponsor-friendly, real estate.
Overviewshow
Profile completeness 47% (high value, high value shallow; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
- Classification
- Single family office (probable)
- Description
- Q••••• C•••••• is a single-family office private equity fund focused on small to midcap life sciences companies
- Headquarters
- New York, NY
- Office address
- unknown
- Business phone
- unknown
- Website
- unknown
- Year established
- unknown
- Assets under management
- unknown
- Capital scale
- Reported office AUM: unknown. No public number of any kind.
Classification history
- Sep 14, 2026Single family office (probable) 70%a filing by a third party describes it as a single family office (cited)Fact
- Sep 14, 2026Candidate 25%no rule matched; held as a candidate pending researchInference
Family and wealth originshow
- Family served
- R••••••• family; W•••• P• R••••••• is sole managing member and owner
- Source of wealth
- unknown
- Operating company origin
- unknown
Team3 peopleshow
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| W•••• R••••••• family | President, Q••••• C•••••• | Family principal · investment decisions | none on record | sec.gov Fact |
| W•••• P• R••••••• | President | Leadership | none on record | sec.gov Fact |
| W•••• R••••••• | President / managing member and owner | Leadership | none on record | sec.gov Fact |
Investment mandateshow
5 i••••••••• on the record (private_equity, public_equity); sectors: biotechnology; last deal 2019-01-01. stated: Life sciences / biotech, concentrated public and private positions
Stated (their words, cited)
- Sectors
- Life sciences / biotech, concentrated public and private positions Inference sec.gov“president of Q••••• C••••••, a single-family office private equity fund focused on investing and supporting small to midcap life sciences companies”
Observed (from the investment record)
- States
- none Fact
- Control
- unknown (3), minority (2) Fact
- Sectors
- biotechnology (4) Fact
- Subsectors
- none Fact
- Co investors
- D•••••••• M••••••••• (1) Fact
- Asset classes
- private equity (3), public equity (2) Fact
- Direct vs fund
- Fund: 0 · Direct: 5 · Real estate: 0 Fact
- Sponsors backed
- none Fact
- Investment count
- 5 Fact
- Investment kinds
- founding investment (3), pipe (1), public equity (1) Fact
- First and last deal
- Last: 2019-01-01 · First: 2009-10-08 Fact
- Lead vs participant
- lead (3), participant (1), unknown (1) Fact
- Disclosed check sizes
- Max: unknown · Min: unknown · Count: 0 Factamounts are only what a source disclosed; never backsolved from a round
Inferred (regulatory shape and team)
Nothing to infer from.
- Invests directly
- unknown
- Allocates to managers
- unknown
- Asset classes
- unknown
- Sectors
- Life sciences / biotech, concentrated public and private positions
- Geography
- unknown
- Check size
- unknown
Direct investments3 dealsshow
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Jan 1, 2019 | T••••• P••••• | Founding investment | biotechnology | lead | unknown | none named | sec.gov Fact “in 2019, he co-founded T••••• P••••• after licensing a novel targeted therapy from Merck KGaA” |
| Jan 1, 2016 | K••••• T••••••••• | Founding investment | biotechnology | lead | unknown | none named | sec.gov Fact “In 2016, Mr. R••••••• also co-founded K••••• T•••••••••” |
| Jan 1, 2012 | A••••• P••••• | Founding investment | biotechnology | lead | unknown | none named | sec.gov Fact “In 2012, Mr. R••••••• co-founded and was the Executive Chairman of A••••• P•••••, a private life sciences company he later sold to AstraZene” |
Fund and manager relationshipsshow
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdingsshow
Stakes the office filed (Schedule 13D, 13G, Section 16)
From EDGAR's index of the office's own filings. A 13D is a stake of 5% or more held with intent, a 13G one held passively, a Form 3, 4 or 5 the office as an insider of the issuer. The size of the stake is inside each filing and is not shown here.
| First filed | Issuer | Filed as | Filings |
|---|---|---|---|
| Jun 13, 2016 | I•••••• B••••••••• | Section 16 insider | the direct beneficial owner of 28,067,333 shares of Common Stock sec.gov |
| Oct 8, 2009 | H••• B••••••••• | Section 16 insider | The investor group is led by a select group of new, experienced life sciences investors, including OrbiMed Advisors LLC and Perceptive Life Sciences Master Fund Ltd., as well as a number of the Company's existing institutional investors, including Q••••• C•••••• LLC, and D•••••••• M•••••••••. globenewswire.com |
Form 13F holdings
No 13F filing on the record for this office.
Real estateshow
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors1show
| Counterparty | Kind | Shared deals | First, last | Examples | Source |
|---|---|---|---|---|---|
| D•••••••• M••••••••• | organisation | 1 | Oct 8, 2009 (historical) | H••• B••••••••• | globenewswire.com |
- D•••••••• M••••••••• Oct 8, 2009 recurring (2) Fact globenewswire.com
- D•••••••• M••••••••• Oct 8, 2009 recurring (2) Fact globenewswire.com
Independent sponsor relationshipsshow
No cited relationship to an independent sponsor.
Related entitiesshow
Signals and timeline6show
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 6 events. 13F position changes are under Public stakes and holdings.
- Apr 28, 2026Office discoveredQ••••• C•••••• described on SEC filings as 'family office' (DEF 14A)DiscoveryFactsec.gov
- Sep 14, 2026Classification changedQ••••• C••••••: CANDIDATE_FAMILY_OFFICE -> PROBABLE_SFO (a filing by a third party describes it as a single family office (cited))c•••••••••Factno URL
- Jan 1, 2019Direct investmentQ••••• C•••••• invested in T••••• P•••••Direct investmentsFactsec.gov
- Jun 13, 2016Direct investmentQ••••• C•••••• invested in I•••••• B•••••••••, Inc.Direct investmentsFactsec.gov
- Jan 1, 2016Direct investmentQ••••• C•••••• invested in K••••• T•••••••••Direct investmentsFactsec.gov
- Jan 1, 2012Direct investmentQ••••• C•••••• invested in A••••• P•••••Direct investmentsFactsec.gov
Sources and evidence12show
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 12 shown.
Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (4 days)
Contactability
+30 n•••• d••••••••• (W•••• P• R••••••• (President); W•••• R••••••• (President / managing member and owner))
Data confidence
+10 d•••••••••
+10 s••••• m••••••
+10 p•••••
+15 i•••••••••
+15 i••••••••• s•••••• (3 sources)
Active deployment
no components; scored 0
Exists confidence
+30 i••••••••• s•••••• (3 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+15 d••••• i••••••••• o• r•••••
+2 n• w•••••• k•••• •••••••• w•••• f••• o•••
+0 r••• (150)
Mandate confidence
+50 m•••••• s•••••••• b• o••••••• i•••••••••
+20 s••••• m•••••• o• t•• r•••••
Identity confidence
+70 c••••••••• (PROBABLE_SFO (a filing by a third party describes it as a single family office (cited)))
Real estate propensity
no components; scored 0
Co investment propensity
+40 c••••••••• o• t•• r••••• (D•••••••• M•••••••••; D•••••••• M•••••••••)
+10 p••••••••• i• s••••••••• r•••••
Family identity confidence
+40 f••••• n•••• (R••••••• family; W•••• P• R••••••• is sole managing member and owner)
+20 f••••• p•••••••• o• s••••
Private markets propensity
+45 p•••••• m•••••• i••••••••• o•••••••
Current activity confidence
+25 a• s••••••••• f••• w••••• 1• m••••• (145 days)
External manager propensity
no components; scored 0
Direct investment propensity
+70 o••••••• d••••• i••••••••• (5 on the record)
Independent sponsor propensity
no components; scored 0
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Board participation | R••••••• is a director and the largest shareholder of I•••••• B•••••••••, joined board June 2016 “Currently, Mr. R••••••• is a board member and our largest shareholder.” | Jun 10, 2025 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Description | Q••••• C•••••• is a single-family office private equity fund focused on small to midcap life sciences companies “president of Q••••• C••••••, a single-family office private equity fund focused on investing and supporting small to midcap life sciences companies” | Jun 10, 2025 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Edgar fts discovery | family office | Apr 28, 2026 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Family served | R••••••• family “W•••• P• R•••••••, Q•••••'s managing member and owner” | n/a | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Family served | R••••••• family; W•••• P• R••••••• is sole managing member and owner “W•••• P• R•••••••, Q•••••'s managing member and owner” | May 8, 2008 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Q••••• C•••••• LLC is a Delaware limited liability company “Q••••• C•••••• LLC, a Delaware limited liability company ("Q•••••"), and W•••• P• R•••••••” | Mar 19, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Liquidity event | R••••••• co-founded and chaired A••••• P•••••, sold to AstraZeneca, a major source of Q•••••'s capital “In 2012, Mr. R••••••• co-founded and was the Executive Chairman of A••••• P•••••, a private life sciences company he later sold to AstraZeneca.” | Jun 10, 2025 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Office type (stated) | single_family_office | Apr 28, 2026 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Sectors | Life sciences / biotech, concentrated public and private positions “president of Q••••• C••••••, a single-family office private equity fund focused on investing and supporting small to midcap life sciences companies” | Jun 10, 2025 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Website search | not_found | Sep 19, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
| Website search | not_found | Sep 16, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
| Website search | not_found | Sep 14, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |